HTGF and MBG back €720,000 seed round for Stimos

The company has identified a need for better implant procedure as 140,000 dental implants, 16,000 hip replacements, 26,000 artificial knees and 40% of all spine surgeries in Germany are unsuccessful.

HTGF said that the technology developed by Stimos addresses a problem that affects both patients and the health economy.

Company
Founded in 2015 by doctors from the University of Konstanz, Stimos develops a biochemical procedure that initiates early and healthy bone formation in implants. It also offers product development and certification services.

People
High-Tech Gründerfonds – Caroline Fichtner (senior investment manager).
MBG Baden-Württemberg – Dirk Buddensiek (managing director).
Stimos - Dietmar Schaffarczyk (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• DACH
• Healthcare
• High-Tech Gründerfonds
• Venture
• Germany